Professor Ulf Müller-Ladner, M.D. |
| ISN Medical Advisory Board |
| Prof. Müller-Ladner has authored and/or coauthored more than 200 research papers and book chapters on basic and clinical immunology and rheumatology disease topics. |
Prior to this position, Prof. Müller-Ladner was Head of the Division of Rheumatology and Clinical Immunology at the University of Regensburg, Germany. Prof. Müller-Ladner is member of the Executive Committee of the German Society of Rheumatology and heading the German Competence Network for Rheumatology. He is also member of the Executive Committee of the EULAR Scleroderma Trials and Research Network (EUSTAR) and the German Network for Systemic Sclerosis. He is a fellow of the American College of Rheumatology, the American Association of Immunologists and the German Societies for Immunology and Gene Therapy. In addition, Prof. Müller-Ladner is serving as a consultant to the German Ministry for Health and Education and the German Research Foundation (DFG). At the latter, he is currently chairing the National Research Program for Clinical Studies. Prof. Müller-Ladner has received his medical degree from the University of Tübingen, Germany and received his internal medicine and rheumatology training at the Universities of Ulm and Regensburg, Germany. He also performed a 2-year basic research fellowship at the Department of Rheumatology of the University of Alabama at Birmingham. Prof. Müller-Ladner has authored and/or coauthored more than 200 research papers and book chapters on basic and clinical immunology and rheumatology disease topics. In addition, he is serving numerous journals in the field of clinical immunology, rheumatology and internal medicine as member of the editorial. Prof. Dr. med. Ulf Müller-Ladner Ulf Müller-Ladner, MD Benekestrasse 2-8 |
| Related Links |
| Welcome Professor Ulf Müller-Ladner, M.D. |
 Professor Ulf Müller-Ladner, MD: ISN Medical Advisory Board. Prof. Müller-Ladner is Chair for Internal Medicine and Rheumatology at the Justus-Liebig University Giessen, Germany, and Director of the Department of Rheumatology and Clinical Immunology at the Kerckhoff-Clinic Bad Nauheim, Germany. Posted 05-29-08. |
| Systemic sclerosis. Systemic sclerosis and its subtypes differ significantly from other diseases in rheumatology and clinical immunology, as the aberrant activation of the immune system does not result in an inflammation-driven destruction but in a progressive matrix synthesis, especially of the skin. (PubMed) Muller-Ladner U. Internist(Berl). 2008 Mar;49(3):278-285. (Also see: Types of Scleroderma ) |
| Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts. A body of evidence has accumulated illustrating that rheumatoid arthritis synovial fibroblasts are active drivers of joint destruction in rheumatoid arthritis. Ulf Müller-Ladner, Caroline Ospelt, Steffen Gay, Oliver Distler, and Thomas Pap, Arthritis Research & Therapy 2007, 9(6): 223. (Also see: Rheumatoid Arthritis and Dr. Oliver Distler: ISN Medical Advisory Board ) |
|
||||||||||||
| Go to Nolan, Heidi | ||||||||||||
|
||||||||||||
Prof. Müller-Ladner is Chair for Internal Medicine and Rheumatology at the